Moberg Pharma AB (publ) (MBGPF)
OTCMKTS · Delayed Price · Currency is USD
0.9900
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Moberg Pharma AB Company Description
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden.
It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013.
Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.
Moberg Pharma AB (publ)
| Country | Sweden |
| Founded | 2006 |
| Industry | Pharmaceutical Preparations |
| Employees | 6 |
| CEO | Anna Ljung |
Contact Details
Address: Gustavslundsvägen 42 Bromma, 167 51 Sweden | |
| Phone | 46 8 52 23 07 00 |
| Website | mobergpharma.se |
Stock Details
| Ticker Symbol | MBGPF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Anna Ljung | Chief Executive Officer |
| Mark Beveridge | Chief Financial Officer |
| Christina Erixon | Chief Operating Officer |